• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Venous thromboembolism after vaginal delivery rising, preventative measures lacking

byDenise PongandLeah Hawkins Bressler, MD, MPH
September 21, 2014
in Cardiology, Emergency, Obstetrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Current rates of venous thromboembolism (VTE) prophylaxis during vaginal delivery hospitalizations are low, with patients having a history of VTE and/or hypercoagulability most likely to receive it.

2. Other risk factors for VTE such as obesity and smoking were not as strongly associated with VTE prophylaxis.

Evidence Rating Level: 2 (Good)

Study Rundown: Venous thromboembolism (VTE) is a common cause of pregnancy-related morbidity and mortality, and rates of VTE events have been increasing in the United States. VTE includes both deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE is more common after cesarean delivery, and prevention of VTE in the U.S. has centered around cesarean deliveries. However, the majority of women undergo vaginal deliveries, and a greater proportion of VTE events occur among women delivering vaginally. Current guidelines for women undergoing vaginal deliveries recommend prophylaxis only for those women who are hypercoagulable and/or have had a prior thromboembolic event. VTE rates have been increasing over time. Some attribute this rise partially to increasing rates of medical risk factors including obesity, smoking and other chronic diseases, and prior work has produced some evidence to support this hypothesis. In the present study, authors found that current VTE prophylaxis practices are consistent with existing guidelines as described above; other known risk factors for VTE such as obesity are not strongly associated with use of prophylaxis. These findings suggest that there may be room to decrease the incidence of VTE by employing prophylaxis for women with multiple risk factors.

Limitations include retrospective design and use of claims data. Future studies exploring cost-effectiveness of VTE prophylaxis among patients with other risk factors are needed to determine whether and how national guidelines should be modified to decrease the incidence of VTE.

Click to read the study in AJOG

Relevant Reading: Thromboembolism in pregnancy: recurrence risks, prevention and management

RELATED REPORTS

Presence of second midwife during the second active stage of labour reduces the risk of severe perineal trauma

SARS-CoV-2 infection during pregnancy associated with severe maternal morbidity, preterm birth, and venous thromboembolism

#VisualAbstract: Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19

In-Depth [retrospective cohort]: This study evaluated the incidence of VTE, defined as deep vein thrombosis (DVT) or pulmonary embolism (PE), and the use of mechanical or pharmacologic VTE prophylaxis among 2,673,986 women who were hospitalized for a vaginal delivery. Outcomes of interest were DVT, PE, and VTE events, as noted by ICD-9 codes on patient records.

Rates of VTE have increased between 2006 and 2012. Only 2.6% of women in the study received VTE prophylaxis; 67.5% of these women received mechanical prophylaxis in the form of graduated compression stockings or pneumatic compression devices. Patients with a history of VTE and hypercoagulability were more likely to receive prophylaxis (RR 10.14, CI 9.74-10.56 and RR 9.32, CI 8.96-9.71 respectively). Prophylaxis was more likely to occur in patients with other established risk factors for VTE, such as obesity (RR 1.29, CI 1.25-1.34).

More from this author: Unexpected delivery outcomes associated with postpartum depression, Postoperative pain similar in robotic and conventional laparoscopy for gynecologic procedures, Intrahepatic cholestasis of pregnancy linked to poor outcomes, Severe acne linked to endometriosis, Postpartum pelvic floor muscles may have limited value

Image: GNUFree/Wiki

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: vaginal deliveryvenous thromboembolism
Previous Post

Vitamin supplementation does not reduce the risk of cataract formation

Next Post

Gemcitabine, chokeberries synergistic in pancreatic cancer model

RelatedReports

Women electing abortion more likely to be victims of domestic violence
Chronic Disease

Presence of second midwife during the second active stage of labour reduces the risk of severe perineal trauma

April 7, 2022
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Hematology

SARS-CoV-2 infection during pregnancy associated with severe maternal morbidity, preterm birth, and venous thromboembolism

March 24, 2022
#VisualAbstract: Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19
StudyGraphics

#VisualAbstract: Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19

January 26, 2022
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children
Cardiology

Aspirin use was not effective at reducing mortality in patients hospitalized with COVID-19

January 25, 2022
Next Post
Adjuvant gemcitabine improves long-term survival rates of patients with pancreatic cancer

Gemcitabine, chokeberries synergistic in pancreatic cancer model

A quarter of youths with assault injury own a gun

U.S. firearm fatality rates differ by state, race, and ethnicity

Early weight gain linked to obesity and cardiovascular health

2 Minute Medicine Rewind September 14 – September 21, 2014

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Wellness Check: Mental Health
  • #VisualAbstract: Addition of elotuzumab to lenalidomide and dexamethasone did not significantly improve survival outcomes in newly diagnosed, transplant-ineligible multiple myeloma
  • #VisualAbstract: Pretreatment with radiotherapy and two cycles of concurrent cisplatin may reduce toxicity in locally advanced nasopharyngeal carcinoma
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.